Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2233362 | 0.77 | GSK3B (0.30) | — | |
| SCHEMBL10028812 | 0.72 | GPR3 (0.36) | MAPT | |
| SCHEMBL19267320 | 0.70 | — | — | |
| SCHEMBL15274377 | 0.69 | KDM4E (0.32) | MAPT | |
| SCHEMBL15281526 | 0.69 | GSK3B (0.33) | — | |
| SCHEMBL10028815 | 0.69 | EGFR (0.33) | — | |
| SCHEMBL15260402 | 0.68 | CYP3A4 (0.32) | — | |
| SCHEMBL1102387 | 0.68 | — | — | |
| SCHEMBL12194757 | 0.67 | GPR3 (0.35) | — | |
| SCHEMBL19220747 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11690283-B2 | Fused dithieno benzothiadiazole polymers for organic photovoltaics | PHILLIPS 66 COMPANY (US) | 2023-06-27 | — | — | US | disclosed |
| US-11690283-B2 | Fused dithieno benzothiadiazole polymers for organic photovoltaics | PHILLIPS 66 COMPANY (US) | 2023-06-27 | — | — | US | disclosed |
| US-20230165128-A1 | FUSED DITHIENO BENZOTHIADIAZOLE POLYMERS FOR ORGANIC PHOTOVOLTAICS | PHILLIPS 66 COMPANY (US) | 2023-05-25 | — | — | US | disclosed |
| US-20230165128-A1 | FUSED DITHIENO BENZOTHIADIAZOLE POLYMERS FOR ORGANIC PHOTOVOLTAICS | PHILLIPS 66 COMPANY (US) | 2023-05-25 | — | — | US | disclosed |
| US-20230165127-A1 | FUSED DITHIENO BENZOTHIADIAZOLE POLYMERS FOR ORGANIC PHOTOVOLATICS | PHILLIPS 66 COMPANY (US) | 2023-05-25 | — | — | US | disclosed |
| US-20230165127-A1 | FUSED DITHIENO BENZOTHIADIAZOLE POLYMERS FOR ORGANIC PHOTOVOLATICS | PHILLIPS 66 COMPANY (US) | 2023-05-25 | — | — | US | disclosed |
| US-11332579-B1 | Fused dithieno benzothiadiazole polymers for organic photovoltaics | PHILLIPS 66 COMPANY (US) | 2022-05-17 | — | — | US | disclosed |
| US-11326019-B1 | Fused dithieno benzothiadiazole polymers for organic photovoltaics | PHILLIPS 66 COMPANY (US) | 2022-05-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11332579-B1 | Fused dithieno benzothiadiazole polymers for organic photovoltaics | ZYX, LBR, TPR | GAA 4524/4885MAPT 280/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.